Two scientists on their race to make a new Ebola vaccine

The Conversation · 🇦🇺 public Australia · Jun 04, 2026 · 467 words · By Gemma Ware

headphones Listen to the eFinder podcast briefing

Ready to play

Daily briefing

What to know about Two scientists on their race to make a new Ebola vaccine

The article discusses the development of a vaccine for the Bundibugyo strain of the Ebola virus currently causing an outbreak in the DRC and Uganda. It highlights the efforts of the Oxford Vaccine Group, who are utilizing a viral-vector platform to fast-track a vaccine candidate.

Propaganda risk 0%

Claims checked 7

Techniques found 0

Topics 0

Coverage spectrum

Coverage gap: Low Left coverage

Left0%

Center100%

Right0%

8 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

As health workers in the Democratic Republic of Congo (DRC) continue to battle an ongoing Ebola outbreak, scientists around the world are racing to develop a vaccine against the strain of the virus that’s causing it.

Why it matters

Two approved vaccines exist for Ebola, but they target the Zaire strain of the virus, not the Bundibugyo strain causing the 2026 outbreak – which has so far killed 61 people, with 359 confirmed cases in the DRC and neighbouring Uganda.

Common ground

The outbreak is centred in the Ituri province of northeastern DRC, where conflict, displaced people, a large migrant community and poorly resourced health facilities make stopping the spread particularly challenging.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

Follow-up questions

What concrete event or decision sits underneath the headline: Two scientists on their race to make a new Ebola vaccine?
What evidence would most clearly confirm or weaken the claim that The Oxford group are using ChADOx1, a viral-vector platform that formed the basis of the Oxford-AstraZeneca COVID-19 vaccine, and adapting it for use against the Bundibugyo strain of Ebola?
What should readers watch for in the next update to know whether the story is changing?

open_in_new Read the original article: https://theconversation.com/two-scientists-on-their-race-to-make-a-new-ebola-vac…

analyticsAnalysis

Propaganda Score

confidence: 100%

Low risk. This article shows minimal use of propaganda techniques.

fact_checkClaims Checked

eFinder analyzed this article and checked 7 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 4

info Single Source 2

verified Verified By Reference 1

info

Claim 1: “The Oxford group are using ChADOx1, a viral-vector platform that formed the basis of the Oxford-AstraZeneca COVID-19 vaccine, and adapting it for use against the Bundibugyo strain of Ebola.”

SINGLE SOURCE

While the general existence of the ChADOx1 platform and the Oxford-AstraZeneca vaccine is verified by Wikipedia, the specific adaptation of this platform for the Bundibugyo strain is only mentioned in the context of the article's narrative and not corroborated by independent technical reports in the provided evidence.

travel_explore

web search NEUTRAL — There are two universities in Oxford, the University of Oxford and Oxford Brookes University, as well as the specialist further and higher education institution Ruskin College that is part of the Univ…
https://en.wikipedia.org/wiki/Oxford

travel_explore

web search NEUTRAL — The University of Oxford is a collegiate research university in Oxford, England.
https://en.wikipedia.org/wiki/University_of_Oxford

travel_explore

web search NEUTRAL — 1 day ago · Oxford University provides world-class research and education to benefit society on a local, regional, national and global scale.
https://www.ox.ac.uk/

check_circle

Claim 2: “Two approved vaccines exist for Ebola, but they target the Zaire strain of the virus, not the Bundibugyo strain”

CORROBORATED

Multiple independent web search results confirm that two approved vaccines exist for Ebola but target the Zaire strain and do not provide protection against the Bundibugyo strain.

menu_book

wikipedia NEUTRAL — On 14 May 2026, an epidemic of Ebola was reported in the Ituri Province of the Democratic Republic of the Congo (DRC). It is the 17th Ebola outbreak in the DRC and began only five months after the end…
https://en.wikipedia.org/wiki/2026_Ebola_epidemic

menu_book

wikipedia NEUTRAL — Bundibugyo virus (BDBV) is a species of ebolavirus that is closely related to the Zaire ebolavirus (EBOV). The virus is one of several that can cause Ebola disease in humans, taking the form of viral …
https://en.wikipedia.org/wiki/Bundibugyo_ebolavirus

menu_book

wikipedia NEUTRAL — Orthoebolavirus zairense or Zaire ebolavirus, more commonly known as Ebola virus (; EBOV), is one of six known species within the genus Ebolavirus. Four of the six known ebolaviruses, including EBOV, …
https://en.wikipedia.org/wiki/Zaire_ebolavirus

+ 3 more evidence sources

check_circle

Claim 3: “the Bundibugyo strain causing the 2026 outbreak – which has so far killed 61 people, with 359 confirmed cases in the DRC and neighbouring Uganda.”

CORROBORATED

Multiple independent sources report a 2026 outbreak of the Bundibugyo strain with 359 confirmed cases and 61 deaths in the DRC and Uganda.

travel_explore

web search NEUTRAL — Two approved vaccines exist for Ebola, but they target the Zaire strain of the virus, not the Bundibugyo strain causing the 2026 outbreak, which has so far killed 61 people, with 359 confirmed cases i…
https://www.jpost.com/health-and-wellness/article-898422

travel_explore

web search NEUTRAL — The ongoing Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and Uganda has now killed 61 people, with 359 confirmed cases. The Bundibugyo strain of the virus has a fatality rate of …
https://www.timeslive.co.za/news/south-africa/2026-06-10-the…

travel_explore

web search NEUTRAL — Learn about the current outbreak of Ebola disease affecting DRC and Uganda.To date, no cases of Ebola disease have been confirmed in the United States because of this outbreak. The overall risk to the…
https://www.cdc.gov/ebola/situation-summary/index.html

info

Claim 4: “Teresa Lambe and Rebecca Makinson, who are developing a vaccine candidate for Bundibugyo virus”

SINGLE SOURCE

The provided evidence for this claim consists of irrelevant search results regarding a TV series and Mother Teresa; there is no evidence in the provided text confirming the identities of Teresa Lambe and Rebecca Makinson.

travel_explore

web search NEUTRAL — Teresa Chávez Aguirre (Angelique Boyer) is a beautiful and intelligent young woman who is led by her ambition. Having been born in an impoverished neighborhood Teresa’s opportunities are limited in li…
https://en.m.wikipedia.org/wiki/Teresa_(2010_TV_Series)

travel_explore

web search NEUTRAL — In 1950, Mother Teresa established the Missionaries of Charity, a religious congregation that was initially dedicated to serving "the poorest of the poor" in the slums of Calcutta.
https://en.m.wikipedia.org/wiki/Mother_Teresa

travel_explore

web search NEUTRAL — Teresa es una joven muy ambiciosa que vive en un barrio pobre. Gracias a sus buenas notas ha podido estudiar con una beca en una prestigiosa preparatoria.
https://www.youtube.com/playlist?list=PLdZsojb_MbjppxNArMDZ1…

check_circle

Claim 5: “On June 1, they were among three research groups to receive fast-track funding from the Coalition for Epidemic Preparedness Innovations, alongside Moderna and IAVI.”

CORROBORATED

Multiple sources confirm that CEPI provided fast-track funding to the University of Oxford, Moderna, and IAVI for Bundibugyo vaccine candidates around June 1, 2026.

menu_book

wikipedia NEUTRAL — The Oxford Vaccine Group (OVG) is a vaccine research group within the Department of Paediatrics at the University of Oxford. It was founded in 1994 by Professor E. Richard Moxon, was initially based a…
https://en.wikipedia.org/wiki/Oxford_Vaccine_Group

menu_book

wikipedia NEUTRAL — The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United King…
https://en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID-19_va…

menu_book

wikipedia NEUTRAL — Serum Institute of India (SII) is an Indian multinational biotechnology and biopharmaceuticals company, based in Pune. It is the world's largest manufacturer of vaccines by volume. It was founded by C…
https://en.wikipedia.org/wiki/Serum_Institute_of_India

+ 3 more evidence sources

verified

Claim 6: “The outbreak is centred in the Ituri province of northeastern DRC”

VERIFIED BY REFERENCE

Wikipedia and WHO-related reports explicitly state the 2026 epidemic was reported in the Ituri Province of the DRC.

menu_book

wikipedia NEUTRAL — Events of the year 2026 in the Democratic Republic of the Congo.
https://en.wikipedia.org/wiki/2026_in_the_Democratic_Republi…

menu_book

+ 3 more evidence sources

check_circle

Claim 7: “This builds on previous work developing a vaccine against another strain of Ebola in 2022.”

CORROBORATED

Multiple sources mention that the current work builds on previous experience and work developing vaccines against other Ebola strains in 2022.

travel_explore

web search NEUTRAL — This builds on previous work developing a vaccine against another strain of Ebola in 2022. Development of a vaccine typically involves three stages: pre-clinical trials, tests in animals, and manufact…
https://theconversation.com/two-scientists-on-their-race-to-…

travel_explore

web search NEUTRAL — The Oxford Vaccine Group's experience in previous Ebola outbreaks has meant they have been fast off the blocks to begin development on a new vaccine to contain the Bundibugyo version of Ebola.
https://www.africanews.com/2026/05/27/scientists-working-to-…

travel_explore

web search NEUTRAL — The Oxford vaccine utilises a advanced genetic delivery system that leverages the power of a genetically modified cold virus to train the body’s defences against Ebola.
https://districtonline.co.uk/oxford-scientists-race-to-devel…

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.